Human loss-of-function mutations in tuberous sclerosis complex (TSC), for example, cardiac rhabdomyomas, present with excess glycogen deposition, correlating with increased mTORC1 activity (48, 49). Here, TSC1 is linked to cardiac rhabdomyoma.